Business
TOMI Reports Accelerating SteraMist Adoption as Ebola Outbreaks and Global Biosecurity Threats Drive Preparedness Spending
Growing demand reflects increasing investment in scalable decontamination technologies across healthcare, emergency response, and critical infrastructure sectorsFREDERICK, Md., June 23, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global leader in disinfection and decontamination technologies, today announced continued growth in customer adoption and commercial demand for its SteraMist® platform as organizations worldwide expand preparedness efforts against emerg
About this update from Tomi Environmental Solutions, Inc.
Growing demand reflects increasing investment in scalable decontamination technologies across healthcare, emergency response, and critical infrastructure sectors FREDERICK, Md., June 23, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global leader in disinfection and decontamination technologies, today announced continued growth in customer adoption and commercial demand for its SteraMist® platform as organizations worldwide expand preparedness efforts against emerging biological threats. Healthcare providers, emergency response agencies, transportation operators, and public health organizations are increasingly investing in advanced infection prevention capabilities as a growing number of pathogen outbreaks reinforce the need for long-term biosecurity infrastructure. Recent outbreaks of Ebola, measles, norovirus, and other highly contagious pathogens have highlighted the ongoing challenge of infectious disease containment. Public health experts increasingly view biosecurity preparedness as a permanent operational requirement rather than a temporary response to isolated events. According to public reports, recent Ebola outbreaks have expanded beyond their original regions and crossed international borders, underscoring the speed at which infectious disease threats can spread in a highly connected world. Governments and healthcare systems continue to invest heavily in preparedness programs designed to improve response capabilities before future outbreaks occur. Against this backdrop, TOMI has expanded deployments with healthcare providers, emergency response teams, and specialized pathogen programs. Internationally, an established partner has broadened SteraMist deployment across emergency medical transport and healthcare facilities to support high-consequence pathogen readiness. In the U.S., healthcare systems and federally supported preparedness programs are increasing adoption of SteraMist to strengthen environmental decontamination protocols. "We continue to see growing recognition that preparedness cannot begin after an outbreak occurs," said Dr. Halden Shane CEO of TOMI Environmental Solutions. "Organizations are investing ahead of potential threats, and they are looking for proven technologies that can be deployed rapidly, effectively, and at scale. We believe SteraMist is uniquely positioned to address ...
View stock analysis, news, and events for Tomi Environmental Solutions, Inc.